International Biotechnology Trust’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.23M | Sell |
137,751
-163,000
| -54% | -$1.46M | 0.41% | 46 |
|
|
2023
Q2 | $3.38M | Sell |
300,751
-133,000
| -31% | -$1.5M | 1.03% | 31 |
|
|
2023
Q1 | $4.99M | Sell |
433,751
-207,317
| -32% | -$2.38M | 1.39% | 24 |
|
|
2022
Q4 | $7.42M | Buy |
641,068
+291,000
| +83% | +$3.37M | 2.29% | 17 |
|
|
2022
Q3 | $4.44M | Buy |
350,068
+346,203
| +8,957% | +$4.39M | 1.42% | 24 |
|
|
2022
Q2 | $563K | Sell |
3,865
-472,135
| -99% | -$68.7M | 5.87% | 3 |
|
|
2022
Q1 | $1.16M | Hold |
476,000
| – | – | 0.26% | 52 |
|
|
2021
Q4 | $5.64M | Buy |
476,000
+226,000
| +90% | +$2.68M | 1.26% | 26 |
|
|
2021
Q3 | $4.06M | Buy |
250,000
+115,000
| +85% | +$1.87M | 0.98% | 30 |
|
|
2021
Q2 | $2.84M | Buy |
135,000
+41,114
| +44% | +$865K | 0.75% | 31 |
|
|
2021
Q1 | $1.45M | Buy |
+93,886
| New | +$1.45M | 0.38% | 40 |
|